Reshma Rangwala
Chief Tech/Sci/R&D Officer presso KARYOPHARM THERAPEUTICS INC.
Patrimonio netto: 363 507 $ in data 30/04/2024
Posizioni attive di Reshma Rangwala
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 | - |
Storia della carriera di Reshma Rangwala
Precedenti posizioni note di Reshma Rangwala
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 15/09/2020 | 28/03/2022 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01/05/2017 | 01/07/2020 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01/06/2012 | 01/05/2017 |
Formazione di Reshma Rangwala
| Duke University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
- Borsa valori
- Insiders
- Reshma Rangwala
- Esperienza
